These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 10460158

  • 21. Miscoding properties of 2'-deoxyinosine, a nitric oxide-derived DNA Adduct, during translesion synthesis catalyzed by human DNA polymerases.
    Yasui M, Suenaga E, Koyama N, Masutani C, Hanaoka F, Gruz P, Shibutani S, Nohmi T, Hayashi M, Honma M.
    J Mol Biol; 2008 Apr 04; 377(4):1015-23. PubMed ID: 18304575
    [Abstract] [Full Text] [Related]

  • 22. Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities.
    Trimmer EE, Zamble DB, Lippard SJ, Essigmann JM.
    Biochemistry; 1998 Jan 06; 37(1):352-62. PubMed ID: 9425057
    [Abstract] [Full Text] [Related]

  • 23. Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta.
    Alt A, Lammens K, Chiocchini C, Lammens A, Pieck JC, Kuch D, Hopfner KP, Carell T.
    Science; 2007 Nov 09; 318(5852):967-70. PubMed ID: 17991862
    [Abstract] [Full Text] [Related]

  • 24. Proteins that bind to and mediate the biological activity of platinum anticancer drug-DNA adducts.
    Whitehead JP, Lippard SJ.
    Met Ions Biol Syst; 1996 Nov 09; 32():687-726. PubMed ID: 8640535
    [No Abstract] [Full Text] [Related]

  • 25. Translesion synthesis past equine estrogen-derived 2'-deoxycytidine DNA adducts by human DNA polymerases eta and kappa.
    Suzuki N, Yasui M, Santosh Laxmi YR, Ohmori H, Hanaoka F, Shibutani S.
    Biochemistry; 2004 Sep 07; 43(35):11312-20. PubMed ID: 15366941
    [Abstract] [Full Text] [Related]

  • 26. Binding of tsHMG, a mouse testis-specific HMG-domain protein, to cisplatin-DNA adducts.
    Ohndorf UM, Whitehead JP, Raju NL, Lippard SJ.
    Biochemistry; 1997 Dec 02; 36(48):14807-15. PubMed ID: 9398202
    [Abstract] [Full Text] [Related]

  • 27. Single d(GpG)/cis-diammineplatinum(II) adduct-induced inhibition of DNA polymerization.
    Suo Z, Lippard SJ, Johnson KA.
    Biochemistry; 1999 Jan 12; 38(2):715-26. PubMed ID: 9888812
    [Abstract] [Full Text] [Related]

  • 28. LEF-1 recognition of platinated GG sequences within double-stranded DNA. Influence of flanking bases.
    Chválová K, Sari MA, Bombard S, Kozelka J.
    J Inorg Biochem; 2008 Feb 12; 102(2):242-50. PubMed ID: 17961652
    [Abstract] [Full Text] [Related]

  • 29. Replication inhibition and translesion synthesis on templates containing site-specifically placed cis-diamminedichloroplatinum(II) DNA adducts.
    Comess KM, Burstyn JN, Essigmann JM, Lippard SJ.
    Biochemistry; 1992 Apr 28; 31(16):3975-90. PubMed ID: 1314653
    [Abstract] [Full Text] [Related]

  • 30. Impact of the stereochemistry of benzo[a]pyrene 7,8-dihydrodiol 9,10-epoxide-deoxyadenosine adducts on resistance to digestion by phosphodiesterases I and II and translesion synthesis with HIV-1 reverse transcriptase.
    Chary P, Lloyd RS.
    Chem Res Toxicol; 1996 Mar 28; 9(2):409-17. PubMed ID: 8839043
    [Abstract] [Full Text] [Related]

  • 31. The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts.
    Vaisman A, Varchenko M, Umar A, Kunkel TA, Risinger JI, Barrett JC, Hamilton TC, Chaney SG.
    Cancer Res; 1998 Aug 15; 58(16):3579-85. PubMed ID: 9721864
    [Abstract] [Full Text] [Related]

  • 32. Sequence context modulation of translesion synthesis at a single N-2-acetylaminofluorene adduct located within a mutation hot spot.
    Burnouf DY, Miturski R, Fuchs RP.
    Chem Res Toxicol; 1999 Feb 15; 12(2):144-50. PubMed ID: 10027791
    [Abstract] [Full Text] [Related]

  • 33. Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin.
    Takahara PM, Rosenzweig AC, Frederick CA, Lippard SJ.
    Nature; 1995 Oct 19; 377(6550):649-52. PubMed ID: 7566180
    [Abstract] [Full Text] [Related]

  • 34. Effects of a piperidine ligand on DNA modification by antitumor cisplatin analogues.
    Kasparkova J, Novakova O, Najajreh Y, Gibson D, Perez JM, Brabec V.
    Chem Res Toxicol; 2003 Nov 19; 16(11):1424-32. PubMed ID: 14615968
    [Abstract] [Full Text] [Related]

  • 35. Translesion synthesis past estrogen-derived DNA adducts by human DNA polymerases eta and kappa.
    Suzuki N, Itoh S, Poon K, Masutani C, Hanaoka F, Ohmori H, Yoshizawa I, Shibutani S.
    Biochemistry; 2004 May 25; 43(20):6304-11. PubMed ID: 15147214
    [Abstract] [Full Text] [Related]

  • 36. A single amino acid governs enhanced activity of DinB DNA polymerases on damaged templates.
    Jarosz DF, Godoy VG, Delaney JC, Essigmann JM, Walker GC.
    Nature; 2006 Jan 12; 439(7073):225-8. PubMed ID: 16407906
    [Abstract] [Full Text] [Related]

  • 37. Translesion synthesis in Escherichia coli: lessons from the NarI mutation hot spot.
    Fuchs RP, Fujii S.
    DNA Repair (Amst); 2007 Jul 01; 6(7):1032-41. PubMed ID: 17403618
    [Abstract] [Full Text] [Related]

  • 38. The effect of DNA structure on the catalytic efficiency and fidelity of human DNA polymerase beta on templates with platinum-DNA adducts.
    Vaisman A, Warren MW, Chaney SG.
    J Biol Chem; 2001 Jun 01; 276(22):18999-9005. PubMed ID: 11259423
    [Abstract] [Full Text] [Related]

  • 39. Energetics, conformation, and recognition of DNA duplexes containing a major adduct of an anticancer azolato-bridged dinuclear Pt(II) complex.
    Mlcouskova J, Malina J, Novohradsky V, Kasparkova J, Komeda S, Brabec V.
    Biochim Biophys Acta; 2012 Oct 01; 1820(10):1502-11. PubMed ID: 22683702
    [Abstract] [Full Text] [Related]

  • 40. Structural basis for the bypass of the major oxaliplatin-DNA adducts by human DNA polymerase η.
    Ouzon-Shubeita H, Baker M, Koag MC, Lee S.
    Biochem J; 2019 Feb 28; 476(4):747-758. PubMed ID: 30709915
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.